Granted Patent B2

US 10,500,155 · App. 15/879,740 · Granted Dec 10, 2019

Abstract

Claims (15)

1. A lozenge dosage form comprising:

a disintegrative tablet portion; and

a candy glass shell portion;

wherein the disintegrative tablet portion comprises at least one pharmaceutically active ingredient;

wherein the disintegrative tablet portion has a form of a plug as depicted in FIG. 3 ;

wherein the plug is added to the candy glass shell portion after the candy glass shell portion is formed;

wherein pressure and/or heat is added to the plug to fill in a predefined space within the candy glass shell portion;

wherein the candy glass shell portion has a form of a spherical cap as depicted in FIG. 1 ; and

wherein when combined the disintegrative tablet portion and the candy glass shell portion have a form as depicted in FIG. 2 .

2. The lozenge dosage form of claim 1 , wherein the candy glass shell portion comprises at least one pharmaceutically active ingredient.

3. The lozenge dosage form of claim 1 , wherein the disintegrative tablet portion comprises at least two excipients selected from the group consisting of a poloxamer, polyethylene glycol, a sugar, a starch and a starch hydrosylate.

4. The lozenge dosage form of claim 1 , wherein the disintegrative tablet portion comprises multiple layers.

5. The lozenge dosage form of claim 4 , wherein the disintegrative tablet portion comprises two layers, wherein a first layer comprises a first pharmaceutically active ingredient, and wherein a second layer comprises a second pharmaceutically active ingredient.

6. The lozenge dosage form of claim 5 , wherein the first layer and the second layer are exposed on a surface of the dosage form.

7. A method of treating an ailment comprising orally administering the lozenge dosage form of claim 1 .

Assignments (7)